Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green Harbor Investment is a private equity investment firm established in 2015–2016 and based in Beijing, China with additional presence in Hong Kong. The firm manages over RMB 6 billion and focuses on investments across autonomous driving, carbon neutrality, and healthcare technology sectors. It does not develop drugs or own clinical programs itself but provides capital and strategic support to portfolio companies within these industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Harbor Investment.